BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Lone Star Bio

  Metiscan, Inc. Announces Share Buyback Program

  August 11, 2009

   · 

  3 min read
• Business

  Dutch Crucell N.V. Posts Q2 Net Loss, Shares Drop

  August 11, 2009

   · 

  1 min read
• Business

  Taro Pharmaceutical Industries Ltd. Provides Preliminary First Half 2009 Financial Results

  August 11, 2009

   · 

  1 min read
• Bio NC

  Chimerix, Inc. Raises $16.1 Million in Series E Financing

  August 11, 2009

   · 

  2 min read
• Business

  Antisoma PLC and Bryan Oncor, Inc. Announce Deal for Anti-Cancer Drug P2045

  August 11, 2009

   · 

  1 min read
• Drug Development

  Javelin Pharmaceuticals Pain Drug Ereska (Intranasal Ketamine) Misses Key Phase 3 Study Goal

  August 11, 2009

   · 

  5 min read
• Drug Development

  Crucell N.V. Sees Government Interest in Novel Flu Drug

  August 11, 2009

   · 

  1 min read
• Business

  Dako A/S Enters Collaboration with Genentech, Inc. (JOBS) on Diagnostic Tests for Patients with Stomach Cancer

  August 11, 2009

   · 

  4 min read
• Drug Development

  Amgen: Studies Published in The New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss Twice-Yearly Administration of Denosumab

  August 11, 2009

   · 

  14 min read
• Drug Development

  Omeros Corporation Announces Positive Clinical Results of Phase 1/Phase 2 Trial of OMS302 for Use During Ophthalmologic Surgery

  August 11, 2009

   · 

  2 min read